We sit down with you and build your perfect lead list. Book a call with founders.

Pirouette Pharma Analysis: $6M Raised

What is Pirouette Pharma?

Pirouette Pharma develops innovative healthcare solutions, focusing on advanced drug delivery systems and therapies to enhance patient care and improve lives.

Employees
9
Founded
2017
Company Stage
Seed
Investors
- Safar Partners - Y Combinator
YC Batch
S21

Product Features & Capabilities

  • Emergency auto-injector for severe allergic reactions, potential for opioid overdose treatment, advanced drug delivery systems.

How much Pirouette Pharma raised

Community Round (not specified) - $6,049,106

Closing on March 13, 2024
Lead Investor: 3,898 investors, backed by Y Combinator, Safar Partners, Liquid 2 Ventures, Gaingels

Who are the founders of Pirouette Pharma

MK

Matthew Kane

COO, Founder

EK

Elijah Kapas

CTO, Founder

Find more companies like Pirouette Pharma

in Y Combinator batch S21 companies

Financial Overview

$6MTotal Raised
Community Round (not specified)$6,049,106
Closing on March 13, 2024
Investors: 3,898 investors, backed by Y Combinator, Safar Partners, Liquid 2 Ventures, Gaingels
Want to research more data points on Pirouette Pharma?
Start with Extruct